Skip to main content

Table 1 Clinical characteristics of the included patients

From: Primary immunodeficiency associated with chromosomal aberration – an ESID survey

Nr

Sex

Age (yrs)1

Genetics

Immunological presentation2

Other clinical presentations3

Other symptoms

1

M

15.2

46, XY, dup(6) (p12.2p21.31)

Airways

Developmental delay

Dysmorphic features

Microcephaly

Prematurity 36 weeks

Tracheostomy

Feeding difficulties

Infantile pyloric stenosis

Pulmonary congestion

Intractable diarrhoea

2(a)

M

3.4

46, XY.ish der(16)t(16;19) (p13.3;p13.3) arr[hg19] 16p13.3(106 271–1 024 153)x1, 19p13.3 (327 273–6 887 622)x3

Failure to thrive

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Microcephaly

Growth retardation

Bilateral inguinal hernia

Horse shoe kidney

Hypospadia, hydrocele

Maldescensus testis

3(a)

M

9.4

46, XY.ish der(14)t(14;19) (p11.2;p13.2) de novo; arr[hg19] 19p13.3p13.2(90 897–7 300 043)x3

Unusual infections

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Microcephaly

Growth retardation

Bilateral incarcerated inguinal hernia

Congenital hip dysplasia

Perineal hypospadia/penoscrotal fistula

Severe osteopenia

Sensorineurinal hearing loss

Epilepsy

4

M

5.6

46, XY, del(18) (p11.2)

Airways

Ataxia, paresis or other motor disability

Growth retardation

na

5

M

12.0

47, XY, +13

Airways

Developmental delay

Growth retardation

Sepsis

Seizures

Gastroesophageal reflux disease

Loss of vision

6

F

6.1

46, XX, del(16) (p11.2)

Airways

Developmental delay

Dysmorphic features

Obesity

Autism

BCGosis

7

M

5.1

46, XY, del(2) (q33.2)

AI disease

Developmental delay

Dysmorphic features

Cleft palate

PDA

Splenomegaly

Auto-immune hemolytic anemia

8

M

1.0

No full karyotype available

Array CGH : gain of 144kB in 9p24.3 and loss of 15MB in 10q26.11.q26.3

Unusual infections

Developmental delay

Dysmorphic features

Microcephaly

Growth retardation

Duodenal atresia

PDA

Micropenis, gonadal agenesia

9

F

5.2

46, XX, del(18) (q22)

AI disease

Developmental delay

Dysmorphic features

Auto-immune polyendocrine syndrome type II with:

Thyroiditis

Vitiligo

Pernicious anemia

Type 1 diabetes mellitus

10

F

1.4

46, XX, arr[hg19] 16p11.2

(29, 567, 295-30, 177, 916)x1 dn

Failure to thrive

Developmental delay

Growth retardation

Recurrent fever

11

F

69.2

45, X

Airways

Dysmorphic features

Growth retardation

Schwannoma

Hearing loss

12

F

6.5

45, X[42]/47, XXX [8]

Airways

Developmental delay

Growth retardation

Currarino syndrome

13

F

41.6

45, X

Unusual infections

Growth retardation

na

14

M

20.1

46, XY, der(X)t(X;18) (q28;q23)

(MECP2 duplication)

Airways

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Vitiligo

Bronchiectasis

Small intestinal villous atrophy

15(b)

M

7.5

46, XY, r(18)(p11.2q23) [97]/45, XY, -18 [3]

Airways

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Microcephaly

Growth retardation

ASD II, VSD

Micropenis

16(c)

F

47.7

arr[hg19] 11q24.2q25

(126, 074, 297-134, 927, 114)x1

Airways

Developmental delay

Dysmorphic features

Atopic eczema

VSD

Infertility

HPV associated giant condylomata

Hypothyroid

Idiopathic angio-edema

Severe asthma

Hypersplenism

Obesity, type II diabetes

Bronchiectasis

17(d)

M

22.3

46, XY, der(18)t(10p;18q) with 18q22.3–q23 deletion and partial trisomy of 10pter

Airways

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Growth retardation

Hypothyroid (subclinical)

Pulmonary valve stenosis

18(e)

F

29.3

46, XX, t(12;14) (p11.2;q13)

AI disease

Atopic eczema

Samter's triad*

ALL

Migraine

Recurrent herpes labialis

HPV associated condylomata

Multiple allergies

19(e)

F

4.9

46, XX, t(12;14) (p11.2;q13)

Airways

None

na

20(d)

F

28.2

46, XX, der(18)t(10p;18q) with 18q22.3–q23 deletion and partial trisomy of 10pter

Airways

Ataxia, paresis or other motor disability

Dysmorphic features

Atopic eczema

Thymus hyperplasia

Atopy

Polyarticular JIA

21

F

31.3

46, XX, arr[hg19] 15q25.2

(83, 214, 012-84, 776, 990)x1

Airways

None

Allergy

Epilepsy

Asthma

Cholesteatoma

Recurrent monoarthritis

22

M

34.3

46, XY, inv(10)(q21q23)

AI disease

None

Asymptomatic

23(f)

F

6.9

46, XX, del(19)(p13.13)

Airways

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Microcephaly

Growth retardation

IUGR

Epilepsy

24(f)

M

9.6

46, XY, r(18)

AI disease

Developmental delay

Dysmorphic features

Growth retardation

Hypopigmentation

Panniculitis with lipodystrophy

Auto-immune hypothyroidism

Vitiligo

Chronic urticaria

Subaortic stenosis

25(g)

M

16.8

46, XY, der(11)dup(11) (q22q23)del(q24.3)

Airways

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Atopic eczema

Hair and/or nail abnormalities

na

26

M

3.7

No full karyotype available

arr[hg19]11p12-p11.12 (38.090.281-49.257.082)x1

Airways

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Defective absorption folinic acid

27

F

10.3

46, XX, del(11)(q11)

Failure to thrive

Developmental delay

Dysmorphic features

Growth retardation

Atopic eczema

na

28

F

5.9

49, XXXXX

Pyogenic infections

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

PS and ASD

Hypermobility

Radio-ulnar synosthosis

29

M

15.1

46, XY.ish del(X) (p11.3p11.3)

(RP4-628F15+, RP11-245M24 dim, RP6-99M1-, RP4-689N3-, RP11-1409+)mat

Failure to thrive

Developmental delay

Microcephaly

Growth retardation

Visual impairment

Retinitis pigmentosa

30

M

9.4

46, XY, r(6)

Airways

Developmental delay

Dysmorphic features

Microcephaly

Growth retardation

Gastro-oesofageal reflux

Dilated cardiomyopathy and small VSD

31(h)

F

12.8

46, XX, del(18)(p11.1)

Airways

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Growth retardation

Type I diabetes mellitus

Growth hormone deficiency

Autoimmune thyroiditis

Pectus excavatum

Retrognathia with absent maxillary chondyles

32

M

6.8

46, XY, del(7)(q22.3 q31.3)

Airways

Developmental delay

Dysmorphic features

na

33

F

14.7

47, XX, +der(22)t(11;22) (q23;q11) mat (partial trisomy 11q)

Airways

Developmental delay

Ataxia, paresis or other motor disability

Palatoschizis, preauricular tags

Anus atresia

Urolithiasis

34

F

7.9

46, XX.arr snp 2p23.1 (SNP_A-2078092->SNP_A-2248377)x1 mat

Same pathogen

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Mitochondrial dysfunction

Acracyanosis

Bronchiectasis

Hyposplenia

35

M

11.3

46, XY.arr[hg19] 3p14.3 (57, 994, 310-58, 071, 249)x1 pat

Airways

Developmental delay

Dysmorphic features

Submucosal palatal schisis

Transient neonatal macroglossi

Hepatosplenomegaly

36

F

6.8

45, X

Airways

None

na

37

F

20.2

46, XX, der(2)t(2;10)(q37.3;q26.3)mat.arr snp 2q37.2q37.3(SNP_A-1957498->SNP_A-2027809)x1,10q26.3 (SNP_A-2264115->SNP_A-1934598)x3

Airways

Developmental delay

Ataxia, paresis or other motor disability

Autistiform developmental delay

Splenomegaly

Cytopenias

Granulomata

Gastroparesis

Obesitas

38(i)

M

6.5

49, XXXXY

Airways

Developmental delay

Dysmorphic features

na

39(i)

M

10.6

49, XXXXY

Airways

Developmental delay

Dysmorphic features

na

40(i)

M

14.6

49, XXXXY

Airways

None

na

41(i)

M

13.3

49, XXXXY

Airways

Developmental delay

Dysmorphic features

na

42(i)

M

11.7

49, XXXXY

Airways

Developmental delay

Dysmorphic features

Atopic eczema

na

43

M

12.2

47, XYY, dup(22) (q11.21)

Pyogenic infections

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Microcephaly

Asthma

44

F

3.8

46, XX.arr snp 1q44 (SNP_A-2136114->SNP_A-4223408)x1 dn, 11p11.2p11.12 (SNP_A-1817808->SNP_A-4198132)x3 pat

Airways

Developmental delay

Dysmorphic features

Microcephaly

Growth retardation

Atopic eczema

Epilepsy

Rocker bottom foot

Cow’s milk allergy

Feeding difficulties

45

F

6.7

46, X, idic(X) (p11.21).arr snp 22q11.21 (SNP_A-2108791->SNP_A-2160861)x3 mat, Xp22.33p11.21(SNP_A-4207883->2247707)x1 dn, Xp11.21q28(SNP_A-4201150->SNP_A-2267820)x3 dn

Airways

Developmental delay

Growth retardation

Prematurity; gestational age 30 weeks

Bone anchored hearing aid

Periorbital hemangioma

46

F

12.9

46, XX, arr cgh 16p13.11p13.12

(14, 687, 636-16, 452, 200) x3.

Airways

Developmental delay

Ataxia, paresis or other motor disability

Dysmorphic features

Microcephaly

Growth retardation

Atopic eczema

Severe scoliosis

Seizures

Myopathy of unknown etiology

Chronic progressive external ophthalmoplegia

Contractures; wheelchair bound

  1. Headings: Nr = patient number; 1at the time of reporting; 2most prominent clinical immunological presentation; 3other clinical presentations as requested in the survey (Additional file 1)
  2. Patients: (a) previously published in Seidel MG, Duerr C, Woutsas S, et al. J Med Genet 2014;51:254–263, (b) previously published in Celmeli F, et al. J Investig Allergol Clin Immunol. 2014;24(6):442–4, (c) previously published in Seppänen et al. J Clin Immunol 2014;34:114–118., (d) family members and previously published in Dostal et al. International Journal of Immu-genetics 2007;34: 143–147 : patient 17 as IV:4 and patient 20 as IV, (e) family members, together with excluded patient 2, 3 and 4, (f) publication in press, Calvo Campoverde K, et al. Allergologia et Immunopathologia 2016, (g) previously published in Fernandez-San Jose C, J Paediatr Child Health 2011;47(7):485–6, (h) previously published in Browning MJ, J Investig Allergol Clin Immu-l 2010;20(3):263–266, (i) previously published in Keller MD, et al. Am J Med Genet C Semin Med Genet. 2013;163C(1):50–4
  3. Clinical presentations: Airways = Recurrent ENT and airway infections; FTT = failure to thrive from early infancy; unusual infections = unusual infections or unusually severe course of infections; AI disease = autoimmune or chronic inflammatory disease, lymphoproliferation; pyogenic infections = recurrent pyogenic infections; same pathogen = recurrent infections with the same type of pathogen (de Vries E. Clin Exp Immunol 2012;167(1):108–19.)
  4. Other abbrevations: ALL acute lymphatic leukemia, ASD atrial septum defect, BCG Bacillus Calmette-Guérin, F female, HPV human papilloma virus, IUGR intra uterine growth retardation, JIA juvenile idiopathic arthritis, M male, na not available, PDA patent ductus arteriosus, PEG percutaneous endoscopic gastrostomy, PS pulmonary stenosis, VSD ventricular septum defect, yrs: years
  5. * Samter’s triad: asthma, aspirin and NSAID sensitivity, and nasal/ethmoidal polyposis